Other GLP-1 agonist drugsa class that includes Mounjaro and Zepbound, which have the same active ingredienthave also been approved to reduce the risk of heart attack and stroke in overweight people
It's important to note that GLP-1 medications themselves have a low risk of causing hypoglycaemia unless combined with insulin or sulphonylureas, where blood glucose monitoring is particularly important
If a package is held at customs and reaches room temperature, the medication may lose its effectiveness or become unsafe
Tirzepatide, evaluated in the pooled SURPASS trials, maintained superior glycemic control and 5% weight loss at 40-52 weeks in a population with type 2 diabetes, outperforming semaglutide and insulin comparators [13]
They are used for chronic weight management and, in some cases, type 2 diabetes management, depending on the specific medication and indication
Methods: CCA cell lines and normal cholangiocytes were treated with ferroptosis inducers (RSL3, erastin) followed by assessment of cell viability, cellular and mitochondrial iron levels, and phospholipid peroxidation